Latest News for: rdeb
Edit
INmune Bio Advances CORDStrom™ Towards UK Marketing Authorization in RDEB (Form 8-K) (INmune Bio Inc)
Public Technologies 13 Feb 2026
INmune Bio Advances CORDStrom™ Towards UK Marketing Authorization in RDEB ... The program incentivizes development of therapies for rare pediatric diseases like RDEB by awarding a transferable priority review voucher upon approval.
Edit
INmune Bio Advances CORDStrom™ Towards UK Marketing Authorization in RDEB
Nasdaq Globe Newswire 10 Feb 2026
Pre-submission package is a process that facilitates early feedback from the United Kingdom (UK) Medicines and Healthcare Products Regulatory Agency (MHRA), designed to streamline the final approval process and reduce time to market ... .
- 1